Radiesse dose, dilution and treatment intervals: points to consider

This is the author’s interpretation of a conference panel discussion. Study details, statistics and original publications require verification; 1:1 or 1:2 dilution and three-month intervals are not presented as standard treatment instructions.

One of the most interesting sessions at the Merz Global Longevity Summit in New York was a panel discussion. Lectures present organized research findings; panels reveal what experts are considering in practice and where their opinions differ.

The discussion of Radiesse (calcium hydroxylapatite, CaHA)—its dose, dilution, injection plane and treatment intervals—was particularly memorable.

Why do responses differ between patients treated with the same product? Is producing more collagen always better? Does repeating treatment while remodeling is still under way necessarily help? Here are some of the questions raised during the panel.

1. Small amounts over several visits, or a sufficient amount over one or two?

One panelist described a personal preference for treating with a sufficient dose over one or two sessions. The point was not simply to use more product. It was to assess the face and skin and anticipate where and how much treatment might be needed.

Responses may depend on:

• Dose: the amount injected
• Dilution: the dilution ratio
• Injection plane: the tissue layer treated
• Technique: how the material is delivered
• Tissue condition: the patient’s tissues

A patient needing structural support in a deeper layer has a different goal from a patient being considered for more superficial biostimulation. Before counting vials, it is useful to ask what tissue change is being sought.

This does not mean higher doses are better for everyone. Product labeling, anatomical risks and individual indications matter.

2. Is 1:1 or 1:2 dilution better?

A panelist described differences in tissue responses in a particular study comparing 1:1 and 1:2 dilution. The panel account described stronger responses with 1:1 dilution for skin thickness, microcirculation, muscle-related functional measures and some collagen outcomes. It described more favorable elastic-fiber findings with 1:2 dilution.

Changing dilution may change particle concentration per unit volume and distribution in tissue, potentially affecting cells and extracellular matrix responses. More diluent is not necessarily better, nor is greater concentration always superior.

The outcomes being assessed differ depending on whether the focus is collagen, elastic fibers or skin elasticity. These were findings described during the panel about a particular study, not an established standard ratio for all patients. Study design and statistical significance still require checking against the original publication.

3. Does more collagen always mean healthier skin?

I consider this an important question in regenerative medicine. Collagen is a major structural protein, but healthy tissue is not defined solely by its quantity. Collagen type and arrangement, elastic fibers, vessels and extracellular matrix organization also matter.

Regeneration and fibrosis need to be distinguished. Regeneration describes changes toward restoring tissue structure and function. Fibrosis involves excessive or abnormal accumulation of connective-tissue components, potentially reducing flexibility and function.

An increase in collagen alone cannot establish that true regeneration has occurred. When assessing biostimulators, I therefore consider tissue quality and functional changes as well as collagen quantity.

4. Does repeating Radiesse every three months improve regeneration?

One expert described substantial inflammation-related tissue responses still present at three months in a study. Changes were observed at six months, with discussion of remodeling potentially continuing beyond that point.

A memorable personal interpretation was that repeating injections in the same area at three months deserves caution. If tissue is still proliferating and remodeling, it may need time for that process to progress.

Inflammation during tissue recovery is not necessarily harmful; inflammatory signals also participate in normal healing and remodeling. The challenge is distinguishing normal recovery from pathological chronic inflammation, fibrosis or nodules.

The study account did not prove that retreatment at three months is necessarily harmful. Timing needs to consider the treatment area, dose, prior response and safety.

5. How important are circulation and oxygen supply?

Even newly formed cells require an adequate blood supply to support tissue maintenance and function. Blood carries oxygen and nutrients and helps sustain the environment needed for metabolism and recovery.

Regenerating larger tissues requires more than cell proliferation. Vessel formation, nerve connections and extracellular matrix stability also matter. This is one reason why producing small tissues in a laboratory differs from restoring complex tissue or organ function in a person.

When thinking about skin regeneration, I therefore try to consider circulation, oxygen supply, nutrition, metabolic health and the wider recovery environment as well as the surface of the skin.

This does not mean everyone needs a circulation-directed treatment or oxygen therapy. Any treatment’s usefulness and indication need their own evidence.

6. What makes a good regenerative treatment?

The panel reminded me that “more” and “more often” do not necessarily mean better treatment. Understanding a patient’s tissue, choosing an appropriate treatment depth and amount, and allowing time for assessment may matter more than maximizing dose, frequency or collagen quantity.

Skin aging is more than wrinkles or volume. It involves the dermis, subcutaneous fat, muscle, blood vessels, extracellular matrix and their interactions. I believe aesthetic medicine should continue studying tissue health and function alongside visible changes.

The New York discussion helped me reflect on the direction of regenerative medicine. On returning to Korea, I intend to continue reviewing these studies at 1PM Clinic and to focus on tissue-specific, evidence-informed assessment.

At “1 PM” in life, rather than assuming every change is inevitable with age, we can seek a scientific understanding of how the body changes and recovers. That is my starting point for thinking about healthy aging.

This article is based on a record of the 2026 Merz Global Longevity Summit panel discussion in New York and the author’s personal medical interpretation. Spoken remarks have been edited for readability. Specific study figures and statistical significance require checking against the original publications. This account does not guarantee the effects of any product or treatment or recommend identical treatment for everyone.